Lifeward Ltd. (NASDAQ: LFWD) is extending its upward momentum in today’s trading session, continuing a sharp rally from the previous day. After a strong 33.57% increase the previous session, when it ended at $1.87, LFWD stock has risen 10.64% to $2.07 as of the most recent premarket check. The company’s recent historic deal with one of Germany’s top health insurers is a major factor in this positive trend.
Strategic Partnership with BARMER
A significant contract between Lifeward and BARMER, the second-largest statutory health insurance provider in Germany, was formally concluded last week. For medically approved clients, the contract creates a systematic reimbursement procedure for ReWalk Exoskeletons, a vital assistive device for people with spinal cord injuries.
This agreement streamlines access for insured individuals while reinforcing BARMER’s leadership in the German healthcare sector. Furthermore, it establishes a standard for the wider implementation of exoskeleton insurance coverage, both in Germany and internationally. The collaboration is an important step in expanding access to mobility solutions that improve people’s lives, especially as Lifeward continues to expand into reimbursement programs.
Growing International Insurance Coverage
Over the past year, Lifeward has seen notable progress in insurance reimbursement policies across multiple regions. The company has secured Medicare coverage in the United States, state-backed insurance in Hungary, and now an influential agreement with BARMER in Germany. These developments position Lifeward favorably for further expansion, particularly as it pursues approvals from Medicare Advantage Programs and various commercial insurers in the U.S.
BARMER, which insures more than 8.5 million beneficiaries, has already provided 20 ReWalk Personal Exoskeletons to eligible individuals in recent years. The newly established contract formalizes reimbursement procedures, ensuring that medically qualified beneficiaries can access these devices for daily use under clearly defined conditions.
Upcoming Investor Event and Product Showcase
In addition to this milestone agreement, Lifeward has announced a virtual Investor Event scheduled for next Thursday. Presentations from the company’s executive leadership team will be given throughout the event, offering information on Lifeward’s financial outlook, major initiatives, and strategic direction.
Innovations from Lifeward’s product line, such as the AlterG Anti-Gravity System and the ReWalk Exoskeleton, which are both regarded as industry-leading treatments for neurological and orthopedic disorders, will also be on display during the event.